BioSpace News Archive

Drug Development

COVID-19 Vaccine Runner-Up Update: Who Will Reach the Finish Line Next?

With the Pfizer-BioNTech and Moderna COVID-19 vaccines currently authorized in the U.S. and being distributed and dosed, some of the attention is shifting to Johnson & Johnson’s efforts for its one-shot vaccine.

January 22, 2021
·
4 min read
·
Mark Terry
Drug Development

Clinical Catch-Up: January 18-22

With a presidential inauguration and a federal holiday, it wasn’t an enormously busy week for clinical trial news, but there was a fair amount, nonetheless. Read on to see.

January 22, 2021
·
6 min read
·
Mark Terry
Business

Seasonal Flu Nearly Eradicated During Pandemic, Despite Rising COVID-19 Cases

Despite the rising number of COVID-19 cases reported across the globe, rates of influenza have virtually flatlined across the Northern Hemisphere, leading many doctors and researchers to wonder how this could be replicated in non-pandemic times.

January 22, 2021
·
3 min read
·
Brandon May
Business

47% of Americans Still Hesitant to Get COVID-19 Vaccine, New Poll Says

Americans are still hesitant to be vaccinated against COVID-19, according to just-released research from Invisibly.

January 22, 2021
·
4 min read
·
Gail Dutton
Policy

A Year of COVID-19 Provides Lessons for the Future

One year and more than 410,000 deaths later, the United States is still firmly in the grips of the COVID-19 pandemic.

January 22, 2021
·
3 min read
·
Alex Keown
Business

Pharma Partners Launch Cloud Data-Sharing Initiative

Ten pharmaceutical companies have joined forces again to launch Accumulus Synergy Inc., a non-profit effort to pool data in the cloud and interact with regulators, in the hopes of speeding the drug approval process.

January 22, 2021
·
2 min read
·
Mark Zipkin
FDA

Meaningful Moment for HIV Treatment as FDA Approves ViiV’s Monthly Shot

The drug, a combination of cabotegravir and rilpivirine, is a complete therapy for HIV-1 infection in adults who are virologically suppressed.

January 22, 2021
·
3 min read
·
Mark Terry
Deals

A Look at This Week’s Biotech IPOs

The 2021 trend of biotech initial public offerings (IPOs) continued this week. Here’s a look.

January 22, 2021
·
3 min read
·
Mark Terry
Researchers Decipher the Process that Makes Viruses Infectious

Viruses have undoubtedly always existed, and many of them have caused illnesses that have been known to humankind for thousands of years.

January 22, 2021
·
3 min read
·
Andrea Pinto
Drug Development

GSK’s Challenging Week: Halted Study, Delayed FDA Decision and Departing Exec

GSK has discontinued a Phase II clinical trial evaluating an anti-LAG3 cell depleting monoclonal antibody aimed at treating ulcerative colitis licensed from Immutep Limited following an interim assessment of an Independent Data Monitoring Committee.

January 22, 2021
·
3 min read
·
Alex Keown